Association of HIV neutralizing antibody with lower viral load after treatment interruption in a prospective trial (A5170)

Neutralizing antibodies against autologous human immunodeficiency virus type 1 isolates in patients with increasing CD4 cell counts despite incomplete virus suppression during antiretroviral treatment

L. Sarmati
G. D'Ettorre
E. Nicastri
L. Ercoli
I. Uccella
Anna Paola Massetti
S.G. Parisi
Vincenzo Vullo
M. Andreoni

January 2001

Antiretroviral-treated human immunodeficiency virus (HIV) type I-seropositive individuals can remain...

Neutralizing antibodies against autologous human immunodeficiency virus type 1 isolates in patients with increasing CD4 cell counts despite incomplete virus suppression during antiretroviral treatment

Sarmati, L
D'Ettorre, G
Nicastri, E
Ercoli, L
Uccella, I
Massetti, P
Parisi, Sg
Vullo, V
Andreoni, M

January 2001

Antiretroviral-treated human immunodeficiency virus (HIV) type I-seropositive individuals can remain...

Longitudinal changes in HIV-specific IFN-? secretion in subjects who received Remune™ vaccination prior to treatment interruption

Huang, Kenneth
Boisvert, Marie-Pierre
Chung, Famane
Loignon, Maude
Zarowny, Don
Cyr, Lise
Toma, Emil
Bernard, Nicole

January 2006

Affiliation: Maude Loignon, Lise Cyr & Emil Toma : Département de microbiologie et immunologie, Facu...

Association of HIV neutralizing antibody with lower viral load after treatment interruption in a prospective trial (A5170)

McLinden, Robert J.
Paris, Robert M.
Polonis, Victoria R.
Close, Nicole C.
Su, Zhaohui
Shikuma, Cecilia M.
Margolis, David M.
Kim, Jerome H.

January 2012

We investigated the impact of neutralizing antibodies (NAbs) on CD4 T-cell count and viral load in a...

The Role of Neutralizing Antibodies in HIV-1 infection

Bonsall, David George
Bonsall, David George

February 2011

Human immunodeficiency virus type 1 is a major cause of morbidity and mortality worldwide and there ...

Studies on medical and immunological intervention in HIV-1 infection

Hejdeman, Bo

October 2004

The very first HIV-1 infected patients who received antiretroviral combination therapy (HAART) were ...

Studies on medical and immunological intervention in HIV-1 infection

Hejdeman, Bo

October 2004

The very first HIV-1 infected patients who received antiretroviral combination therapy (HAART) were ...

Immunological analysis of treatment interruption after early highly active antiretroviral therapy

Schellens, I.M.M.
Pogany, K.
Westerlaken, G.H.A.
Borghans, J.A.M.
Miedema, F.
Valkengoed, I.G.
Kroon, F.P.
Lange, J.M.
Brinkman, K.
Prins, J.M.
van Baarle, D.

January 2010

We longitudinally evaluated HIV-specific T-cell immunity after discontinuation of highly active anti...

Broadly neutralizing antibody responses in a large longitudinal sub-Saharan HIV primary infection cohort

Landais, Elise
Huang, Xiayu
Havenar-Daughton, Colin
Murrell, Ben
Price, Matt A
Wickramasinghe, Lalinda
Ramos, Alejandra
Bian, Charoan B
Simek, Melissa
Allen, Susan
Karita, Etienne
Kilembe, William
Lakhi, Shabir
Inambao, Mubiana
Kamali, Anatoli
Sanders, Eduard J
Anzala, Omu
Edward, Vinodh
Bekker, Linda-Gail
Tang, Jianming
Gilmour, Jill
Kosakovsky-Pond, Sergei L
Phung, Pham
Wrin, Terri
Crotty, Shane
Godzik, Adam
Poignard, Pascal

January 2016

Author Summary Understanding how HIV-1-broadly neutralizing antibodies (bnAbs) develop during natura...

Rebound Relationships: An Investigation of HIV-1 Rebound Dynamics and Host Immune Responses During Analytical Treatment Interruption

Salantes, D. Brenda

January 2018

In HIV-infected patients, combination antiretroviral therapy (cART) during HIV-1 infection potently ...

Immunological Analysis of Treatment Interruption After Early Highly Active Antiretroviral Therapy

Schellens, I.M.M.
Pogany, K.
Westerlaken, G.H.A.
Borghans, J.A.M.
Miedema, F.
Valkengoed, I.G.M. van
Kroon, F.P.
Lange, J.M.A.
Brinkman, K.
Prins, J.M.
Baarle, D. van

December 2010

We longitudinally evaluated HIV-specific T-cell immunity after discontinuation of highly active anti...

Rebound Relationships: An Investigation Of Hiv-1 Rebound Dynamics And Host Immune Responses During Analytical Treatment Interruption

Salantes, Danielle Brenda

January 2018

In HIV-infected patients, combination antiretroviral therapy (cART) during HIV-1 infection potently ...

Rebound Relationships: An Investigation of HIV-1 Rebound Dynamics and Host Immune Responses During Analytical Treatment Interruption

Salantes, D. Brenda

January 2018

In HIV-infected patients, combination antiretroviral therapy (cART) during HIV-1 infection potently ...

Randomized clinical trial to assess the impact of the broadly neutralizing HIV-1 monoclonal antibody VRC01 on HIV-1 persistence in individuals on effective ART

Riddler, S.A.
Zheng, L.
Durand, C.M.
Ritz, J.
Koup, R.A.
Ledgerwood, J.
Bailer, R.T.
Koletar, S.L.
Eron, J.J.
Keefer, M.C.
Macatangay, B.J.C.
Cyktor, J.C.
Mellors, J.W.
Hite, M.
Clark, J.
Currin, D.
Tipton, M.
Weinman, R.
Onesi, S.
Hurley, C.
Bunce, C.A.
Storey, S.
Dunaway, S.
Lambert, N.
Berzins, B.
Gottesman, J.
Leonard, M.
Ray, G.
Kittelson, P.
Benson, C.
Muttera, L.
Flynn, T.
Sbrolla, A.
Wiggins, I.
Howard, J.
Arduino, R.C.
Villamil, A.E.
Kessels, L.
Spitz, T.
Campbell, D.
Kudumu, M.
Sise, T.
Nair, A.
Baer, J.
Epperson, K.
Perelson, A.
Jennings, C.
Tressler, R.
Acosta, Ed.
Casazza, J.
Benns, A.
AIDS Clinical Trials Group A5342 Protocol Team

January 2018

Background. Broadly neutralizing monoclonal antibodies (bnMAbs) may promote clearance of HIV-1-expre...

The dynamics of HCV-specific antibody responses in HIV/HCV patients on long-term antiretroviral therapy

Lee, S.
Laiman, A.
French, M.
Flexman, J.
Watson, M.
Price, Patricia

January 2017

Antibody responses have not been fully characterised in chronically HIV/HCV patients receiving antir...

Neutralizing antibodies against autologous human immunodeficiency virus type 1 isolates in patients with increasing CD4 cell counts despite incomplete virus suppression during antiretroviral treatment

L. Sarmati
G. D'Ettorre
E. Nicastri
L. Ercoli
I. Uccella
Anna Paola Massetti
S.G. Parisi
Vincenzo Vullo
M. Andreoni

January 2001

Antiretroviral-treated human immunodeficiency virus (HIV) type I-seropositive individuals can remain...

Neutralizing antibodies against autologous human immunodeficiency virus type 1 isolates in patients with increasing CD4 cell counts despite incomplete virus suppression during antiretroviral treatment

Sarmati, L
D'Ettorre, G
Nicastri, E
Ercoli, L
Uccella, I
Massetti, P
Parisi, Sg
Vullo, V
Andreoni, M

January 2001

Antiretroviral-treated human immunodeficiency virus (HIV) type I-seropositive individuals can remain...

Longitudinal changes in HIV-specific IFN-? secretion in subjects who received Remune™ vaccination prior to treatment interruption

Huang, Kenneth
Boisvert, Marie-Pierre
Chung, Famane
Loignon, Maude
Zarowny, Don
Cyr, Lise
Toma, Emil
Bernard, Nicole

January 2006

Affiliation: Maude Loignon, Lise Cyr & Emil Toma : Département de microbiologie et immunologie, Facu...

Association of HIV neutralizing antibody with lower viral load after treatment interruption in a prospective trial (A5170)

McLinden, Robert J.
Paris, Robert M.
Polonis, Victoria R.
Close, Nicole C.
Su, Zhaohui
Shikuma, Cecilia M.
Margolis, David M.
Kim, Jerome H.

January 2012

We investigated the impact of neutralizing antibodies (NAbs) on CD4 T-cell count and viral load in a...

The Role of Neutralizing Antibodies in HIV-1 infection

Bonsall, David George
Bonsall, David George

February 2011

Human immunodeficiency virus type 1 is a major cause of morbidity and mortality worldwide and there ...

Studies on medical and immunological intervention in HIV-1 infection

Hejdeman, Bo

October 2004

The very first HIV-1 infected patients who received antiretroviral combination therapy (HAART) were ...

Studies on medical and immunological intervention in HIV-1 infection

Hejdeman, Bo

October 2004

The very first HIV-1 infected patients who received antiretroviral combination therapy (HAART) were ...

Immunological analysis of treatment interruption after early highly active antiretroviral therapy

Schellens, I.M.M.
Pogany, K.
Westerlaken, G.H.A.
Borghans, J.A.M.
Miedema, F.
Valkengoed, I.G.
Kroon, F.P.
Lange, J.M.
Brinkman, K.
Prins, J.M.
van Baarle, D.

January 2010

We longitudinally evaluated HIV-specific T-cell immunity after discontinuation of highly active anti...

Broadly neutralizing antibody responses in a large longitudinal sub-Saharan HIV primary infection cohort

Landais, Elise
Huang, Xiayu
Havenar-Daughton, Colin
Murrell, Ben
Price, Matt A
Wickramasinghe, Lalinda
Ramos, Alejandra
Bian, Charoan B
Simek, Melissa
Allen, Susan
Karita, Etienne
Kilembe, William
Lakhi, Shabir
Inambao, Mubiana
Kamali, Anatoli
Sanders, Eduard J
Anzala, Omu
Edward, Vinodh
Bekker, Linda-Gail
Tang, Jianming
Gilmour, Jill
Kosakovsky-Pond, Sergei L
Phung, Pham
Wrin, Terri
Crotty, Shane
Godzik, Adam
Poignard, Pascal

January 2016

Author Summary Understanding how HIV-1-broadly neutralizing antibodies (bnAbs) develop during natura...

Rebound Relationships: An Investigation of HIV-1 Rebound Dynamics and Host Immune Responses During Analytical Treatment Interruption

Salantes, D. Brenda

January 2018

In HIV-infected patients, combination antiretroviral therapy (cART) during HIV-1 infection potently ...

Immunological Analysis of Treatment Interruption After Early Highly Active Antiretroviral Therapy

Schellens, I.M.M.
Pogany, K.
Westerlaken, G.H.A.
Borghans, J.A.M.
Miedema, F.
Valkengoed, I.G.M. van
Kroon, F.P.
Lange, J.M.A.
Brinkman, K.
Prins, J.M.
Baarle, D. van

December 2010

We longitudinally evaluated HIV-specific T-cell immunity after discontinuation of highly active anti...

Rebound Relationships: An Investigation Of Hiv-1 Rebound Dynamics And Host Immune Responses During Analytical Treatment Interruption

Salantes, Danielle Brenda

January 2018

In HIV-infected patients, combination antiretroviral therapy (cART) during HIV-1 infection potently ...

Rebound Relationships: An Investigation of HIV-1 Rebound Dynamics and Host Immune Responses During Analytical Treatment Interruption

Salantes, D. Brenda

January 2018

In HIV-infected patients, combination antiretroviral therapy (cART) during HIV-1 infection potently ...

Randomized clinical trial to assess the impact of the broadly neutralizing HIV-1 monoclonal antibody VRC01 on HIV-1 persistence in individuals on effective ART

Riddler, S.A.
Zheng, L.
Durand, C.M.
Ritz, J.
Koup, R.A.
Ledgerwood, J.
Bailer, R.T.
Koletar, S.L.
Eron, J.J.
Keefer, M.C.
Macatangay, B.J.C.
Cyktor, J.C.
Mellors, J.W.
Hite, M.
Clark, J.
Currin, D.
Tipton, M.
Weinman, R.
Onesi, S.
Hurley, C.
Bunce, C.A.
Storey, S.
Dunaway, S.
Lambert, N.
Berzins, B.
Gottesman, J.
Leonard, M.
Ray, G.
Kittelson, P.
Benson, C.
Muttera, L.
Flynn, T.
Sbrolla, A.
Wiggins, I.
Howard, J.
Arduino, R.C.
Villamil, A.E.
Kessels, L.
Spitz, T.
Campbell, D.
Kudumu, M.
Sise, T.
Nair, A.
Baer, J.
Epperson, K.
Perelson, A.
Jennings, C.
Tressler, R.
Acosta, Ed.
Casazza, J.
Benns, A.
AIDS Clinical Trials Group A5342 Protocol Team

January 2018

Background. Broadly neutralizing monoclonal antibodies (bnMAbs) may promote clearance of HIV-1-expre...

The dynamics of HCV-specific antibody responses in HIV/HCV patients on long-term antiretroviral therapy

Lee, S.
Laiman, A.
French, M.
Flexman, J.
Watson, M.
Price, Patricia

January 2017

Antibody responses have not been fully characterised in chronically HIV/HCV patients receiving antir...

Neutralizing antibodies against autologous human immunodeficiency virus type 1 isolates in patients with increasing CD4 cell counts despite incomplete virus suppression during antiretroviral treatment

L. Sarmati
G. D'Ettorre
E. Nicastri
L. Ercoli
I. Uccella
Anna Paola Massetti
S.G. Parisi
Vincenzo Vullo
M. Andreoni

January 2001

Antiretroviral-treated human immunodeficiency virus (HIV) type I-seropositive individuals can remain...

Neutralizing antibodies against autologous human immunodeficiency virus type 1 isolates in patients with increasing CD4 cell counts despite incomplete virus suppression during antiretroviral treatment

Sarmati, L
D'Ettorre, G
Nicastri, E
Ercoli, L
Uccella, I
Massetti, P
Parisi, Sg
Vullo, V
Andreoni, M

January 2001

Antiretroviral-treated human immunodeficiency virus (HIV) type I-seropositive individuals can remain...

Longitudinal changes in HIV-specific IFN-? secretion in subjects who received Remune™ vaccination prior to treatment interruption

Huang, Kenneth
Boisvert, Marie-Pierre
Chung, Famane
Loignon, Maude
Zarowny, Don
Cyr, Lise
Toma, Emil
Bernard, Nicole

January 2006

Affiliation: Maude Loignon, Lise Cyr & Emil Toma : Département de microbiologie et immunologie, Facu...

Association of HIV neutralizing antibody with lower viral load after treatment interruption in a prospective trial (A5170)

Abstract

Extracted data

Association of HIV neutralizing antibody with lower viral load after treatment interruption in a prospective trial (A5170)

Abstract

Extracted data

Related items

Related items